nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.0175	0.207	CbGpPWpGaD
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.0146	0.173	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—NME1—peripheral nervous system neoplasm	0.00696	0.0825	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.00354	0.042	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.00247	0.0293	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00219	0.026	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00176	0.0209	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00175	0.0207	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00172	0.0204	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00162	0.0192	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.00157	0.0186	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00139	0.0164	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00136	0.0162	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00124	0.0147	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.00111	0.0132	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00107	0.0127	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00104	0.0123	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000921	0.0109	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000911	0.0108	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000826	0.00979	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00082	0.00972	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00079	0.00936	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000757	0.00898	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000711	0.00843	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNS—peripheral nervous system neoplasm	0.000666	0.00789	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NME1—peripheral nervous system neoplasm	0.000638	0.00757	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000633	0.0075	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—COX2—peripheral nervous system neoplasm	0.000614	0.00729	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000586	0.00695	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000558	0.00662	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000512	0.00608	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000466	0.00552	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000446	0.00529	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000405	0.0048	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNS—peripheral nervous system neoplasm	0.000403	0.00478	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000403	0.00478	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000388	0.00461	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NME1—peripheral nervous system neoplasm	0.000387	0.00459	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000379	0.00449	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—COX2—peripheral nervous system neoplasm	0.000372	0.00441	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000355	0.00421	CbGpPWpGaD
Gabapentin—ADORA1—nerve—peripheral nervous system neoplasm	0.000342	0.186	CbGeAlD
Gabapentin—BCAT1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000341	0.00404	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000338	0.00401	CbGpPWpGaD
Gabapentin—ADORA1—ganglion—peripheral nervous system neoplasm	0.000338	0.184	CbGeAlD
Gabapentin—CACNA1B—trigeminal ganglion—peripheral nervous system neoplasm	0.000332	0.18	CbGeAlD
Gabapentin—BCAT1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000325	0.00386	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TH—peripheral nervous system neoplasm	0.00032	0.0038	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00031	0.00368	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000307	0.00364	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00029	0.00344	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000283	0.00336	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000262	0.0031	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000257	0.00304	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000251	0.00298	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000244	0.0029	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000239	0.00284	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000229	0.00272	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000206	0.00245	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.0002	0.00238	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000197	0.00234	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TH—peripheral nervous system neoplasm	0.000194	0.0023	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000192	0.00228	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000186	0.0022	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000182	0.00216	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000181	0.00215	CbGpPWpGaD
Gabapentin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000197	CcSEcCtD
Gabapentin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00018	0.000197	CcSEcCtD
Gabapentin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00018	0.000197	CcSEcCtD
Gabapentin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000196	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000179	0.000195	CcSEcCtD
Gabapentin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000195	CcSEcCtD
Gabapentin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000178	0.000195	CcSEcCtD
Gabapentin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000195	CcSEcCtD
Gabapentin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000194	CcSEcCtD
Gabapentin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000194	CcSEcCtD
Gabapentin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000177	0.000194	CcSEcCtD
Gabapentin—Pain—Etoposide—peripheral nervous system neoplasm	0.000177	0.000194	CcSEcCtD
Gabapentin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000193	CcSEcCtD
Gabapentin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000193	CcSEcCtD
Gabapentin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000193	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000192	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000175	0.00208	CbGpPWpGaD
Gabapentin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000192	CcSEcCtD
Gabapentin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000175	0.000191	CcSEcCtD
Gabapentin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000191	CcSEcCtD
Gabapentin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000191	CcSEcCtD
Gabapentin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00019	CcSEcCtD
Gabapentin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000188	CcSEcCtD
Gabapentin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000188	CcSEcCtD
Gabapentin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000188	CcSEcCtD
Gabapentin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000188	CcSEcCtD
Gabapentin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000187	CcSEcCtD
Gabapentin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000187	CcSEcCtD
Gabapentin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00017	0.000187	CcSEcCtD
Gabapentin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000186	CcSEcCtD
Gabapentin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00017	0.000186	CcSEcCtD
Gabapentin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000185	CcSEcCtD
Gabapentin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000169	0.000185	CcSEcCtD
Gabapentin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000169	0.000185	CcSEcCtD
Gabapentin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.000184	CcSEcCtD
Gabapentin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000184	CcSEcCtD
Gabapentin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000184	CcSEcCtD
Gabapentin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000184	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000167	0.00198	CbGpPWpGaD
Gabapentin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000183	CcSEcCtD
Gabapentin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000183	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000183	CcSEcCtD
Gabapentin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000182	CcSEcCtD
Gabapentin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000182	CcSEcCtD
Gabapentin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.000182	CcSEcCtD
Gabapentin—ADORA1—trigeminal ganglion—peripheral nervous system neoplasm	0.000166	0.0902	CbGeAlD
Gabapentin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000181	CcSEcCtD
Gabapentin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00018	CcSEcCtD
Gabapentin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000164	0.00018	CcSEcCtD
Gabapentin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Gabapentin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Gabapentin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Gabapentin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Gabapentin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Gabapentin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Gabapentin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Gabapentin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000179	CcSEcCtD
Gabapentin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000179	CcSEcCtD
Gabapentin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000178	CcSEcCtD
Gabapentin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000162	0.000178	CcSEcCtD
Gabapentin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000177	CcSEcCtD
Gabapentin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000177	CcSEcCtD
Gabapentin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000176	CcSEcCtD
Gabapentin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000176	CcSEcCtD
Gabapentin—Rash—Vincristine—peripheral nervous system neoplasm	0.000161	0.000176	CcSEcCtD
Gabapentin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000161	0.000176	CcSEcCtD
Gabapentin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000176	CcSEcCtD
Gabapentin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000176	CcSEcCtD
Gabapentin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000176	CcSEcCtD
Gabapentin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000175	CcSEcCtD
Gabapentin—Headache—Vincristine—peripheral nervous system neoplasm	0.00016	0.000175	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000159	0.00189	CbGpPWpGaD
Gabapentin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000174	CcSEcCtD
Gabapentin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000174	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000158	0.00188	CbGpPWpGaD
Gabapentin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000173	CcSEcCtD
Gabapentin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.000172	CcSEcCtD
Gabapentin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000172	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000156	0.00184	CbGpPWpGaD
Gabapentin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000169	CcSEcCtD
Gabapentin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000169	CcSEcCtD
Gabapentin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000168	CcSEcCtD
Gabapentin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000167	CcSEcCtD
Gabapentin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000152	0.000167	CcSEcCtD
Gabapentin—CACNA2D1—brainstem—peripheral nervous system neoplasm	0.000152	0.0827	CbGeAlD
Gabapentin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000167	CcSEcCtD
Gabapentin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000152	0.000166	CcSEcCtD
Gabapentin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000166	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000166	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000165	CcSEcCtD
Gabapentin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000165	CcSEcCtD
Gabapentin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000164	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000164	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000163	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000163	CcSEcCtD
Gabapentin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000148	0.000162	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000162	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000162	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000161	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000161	CcSEcCtD
Gabapentin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00016	CcSEcCtD
Gabapentin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000146	0.00016	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000159	CcSEcCtD
Gabapentin—CACNA1B—cerebellum—peripheral nervous system neoplasm	0.000145	0.0787	CbGeAlD
Gabapentin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000158	CcSEcCtD
Gabapentin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000144	0.000157	CcSEcCtD
Gabapentin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000156	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000156	CcSEcCtD
Gabapentin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000156	CcSEcCtD
Gabapentin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000156	CcSEcCtD
Gabapentin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000155	CcSEcCtD
Gabapentin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000155	CcSEcCtD
Gabapentin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000142	0.000155	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000154	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000154	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000153	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000153	CcSEcCtD
Gabapentin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000153	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000152	CcSEcCtD
Gabapentin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000151	CcSEcCtD
Gabapentin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00015	CcSEcCtD
Gabapentin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000137	0.00015	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000149	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000149	CcSEcCtD
Gabapentin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000148	CcSEcCtD
Gabapentin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000147	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000147	CcSEcCtD
Gabapentin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000146	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000145	CcSEcCtD
Gabapentin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000144	CcSEcCtD
Gabapentin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000132	0.000144	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000144	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000144	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000144	CcSEcCtD
Gabapentin—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000143	CcSEcCtD
Gabapentin—Rash—Etoposide—peripheral nervous system neoplasm	0.00013	0.000143	CcSEcCtD
Gabapentin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00013	0.000143	CcSEcCtD
Gabapentin—Headache—Etoposide—peripheral nervous system neoplasm	0.00013	0.000142	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000142	CcSEcCtD
Gabapentin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000141	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000141	CcSEcCtD
Gabapentin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00014	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00014	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00014	CcSEcCtD
Gabapentin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000139	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000139	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000139	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000138	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000126	0.00149	CbGpPWpGaD
Gabapentin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000137	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000137	CcSEcCtD
Gabapentin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000136	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000136	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000135	CcSEcCtD
Gabapentin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000123	0.000134	CcSEcCtD
Gabapentin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000134	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000133	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000133	CcSEcCtD
Gabapentin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000131	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000131	CcSEcCtD
Gabapentin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00013	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000129	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000129	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000129	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000129	CcSEcCtD
Gabapentin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000128	CcSEcCtD
Gabapentin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000127	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000127	CcSEcCtD
Gabapentin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000127	CcSEcCtD
Gabapentin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000126	CcSEcCtD
Gabapentin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000126	CcSEcCtD
Gabapentin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000126	CcSEcCtD
Gabapentin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000125	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000125	CcSEcCtD
Gabapentin—BCAT1—cerebellum—peripheral nervous system neoplasm	0.000114	0.0619	CbGeAlD
Gabapentin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000124	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000124	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000124	CcSEcCtD
Gabapentin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000124	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000123	CcSEcCtD
Gabapentin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000123	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000122	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000122	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000122	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000122	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000122	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000111	0.00131	CbGpPWpGaD
Gabapentin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000121	CcSEcCtD
Gabapentin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000121	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00012	CcSEcCtD
Gabapentin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000119	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000118	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000108	0.00128	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000117	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000117	CcSEcCtD
Gabapentin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000117	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000116	CcSEcCtD
Gabapentin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000116	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000115	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000115	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000115	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000115	CcSEcCtD
Gabapentin—CACNA2D2—cerebellum—peripheral nervous system neoplasm	0.000104	0.0567	CbGeAlD
Gabapentin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000114	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000114	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000114	CcSEcCtD
Gabapentin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000113	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000113	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000102	0.00122	CbGpPWpGaD
Gabapentin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000112	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000112	CcSEcCtD
Gabapentin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00011	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00011	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00011	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000109	CcSEcCtD
Gabapentin—Pain—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.000109	CcSEcCtD
Gabapentin—Constipation—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.000109	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000107	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000106	CcSEcCtD
Gabapentin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000105	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000105	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000105	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000104	CcSEcCtD
Gabapentin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000104	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000103	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.4e-05	0.00112	CbGpPWpGaD
Gabapentin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000102	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000101	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000101	CcSEcCtD
Gabapentin—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000101	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.0001	CcSEcCtD
Gabapentin—Pain—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.0001	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.0001	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.0001	CcSEcCtD
Gabapentin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	9.68e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	9.6e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.54e-05	9.35e-05	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	9.33e-05	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	9.28e-05	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	9.28e-05	CcSEcCtD
Gabapentin—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.32e-05	9.1e-05	CcSEcCtD
Gabapentin—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.2e-05	8.98e-05	CcSEcCtD
Gabapentin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.93e-05	8.68e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	8.65e-05	CcSEcCtD
Gabapentin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	8.42e-05	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.67e-05	8.39e-05	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	8.31e-05	CcSEcCtD
Gabapentin—CACNA2D1—cerebellum—peripheral nervous system neoplasm	7.5e-05	0.0408	CbGeAlD
Gabapentin—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.37e-05	8.07e-05	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	8.03e-05	CcSEcCtD
Gabapentin—Rash—Epirubicin—peripheral nervous system neoplasm	7.31e-05	8e-05	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.31e-05	7.99e-05	CcSEcCtD
Gabapentin—Headache—Epirubicin—peripheral nervous system neoplasm	7.26e-05	7.95e-05	CcSEcCtD
Gabapentin—ADORA1—cerebellum—peripheral nervous system neoplasm	7.24e-05	0.0394	CbGeAlD
Gabapentin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	7.76e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—AKT1—peripheral nervous system neoplasm	7.06e-05	0.000837	CbGpPWpGaD
Gabapentin—Nausea—Epirubicin—peripheral nervous system neoplasm	6.89e-05	7.54e-05	CcSEcCtD
Gabapentin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	7.47e-05	CcSEcCtD
Gabapentin—Rash—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	7.4e-05	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	7.4e-05	CcSEcCtD
Gabapentin—Headache—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	7.36e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.65e-05	0.000789	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.54e-05	0.000775	CbGpPWpGaD
Gabapentin—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	6.97e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.17e-05	0.000612	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.87e-05	0.000577	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.73e-05	0.000561	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.69e-05	0.000556	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.3e-05	0.00051	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—peripheral nervous system neoplasm	4.28e-05	0.000507	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.93e-05	0.000466	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.66e-05	0.000434	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.01e-05	0.000356	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.87e-05	0.000341	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.54e-05	0.000301	CbGpPWpGaD
